TNF and inflammatory bowel disease: West et al. demonstrated that OSM is the most consistently expressed cytokine in inflamed intestinal tissues of IBD patients and could be a potential biomarker and therapeutic target for IBD, especially for anti-TNF-resistant patients [82].